Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CDC25B | P30305 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7013306 | 1.00 | ALDH1A1 (0.45) | ALDH1A1MAPK1L3MBTL1GLALMNA | |
| SCHEMBL12086008 | 1.00 | ALDH1A1 (0.45) | ALDH1A1MAPK1L3MBTL1GLALMNA | |
| SCHEMBL22817371 | 0.92 | ALDH1A1 (0.43) | ALDH1A1MAPK1L3MBTL1GLALMNA | |
| SCHEMBL11957429 | 0.87 | ALDH1A1 (0.43) | ALDH1A1MAPK1L3MBTL1GLALMNA | |
| SCHEMBL9886347 | 0.86 | GLA (0.55) | ALDH1A1MAPK1L3MBTL1GLACDC25B | |
| SCHEMBL4413019 | 0.86 | GLA (0.55) | ALDH1A1MAPK1L3MBTL1GLACDC25B | |
| SCHEMBL9917628 | 0.86 | GLA (0.55) | ALDH1A1MAPK1L3MBTL1GLACDC25B | |
| SCHEMBL22817417 | 0.84 | MEN1 (0.34) | GLAKMT2A | |
| SCHEMBL9886333 | 0.84 | MEN1 (0.34) | GLAKMT2A | |
| SCHEMBL14901058 | 0.81 | KMT2A (0.38) | ALDH1A1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117860908-A | Double-drug nano-drug delivery system with cisplatin drug and proteinase K coupled and preparation method thereof | 浙江大学长三角智慧绿洲创新中心 | 2024-04-12 | — | — | CN | claimed |
| CN-122005788-A | Application of polyamino acid material in tumor microwave thermal therapy sensitization | 中国科学院理化技术研究所 | 2026-05-12 | — | — | CN | disclosed |
| EP-4709361-A1 | A COMPOUND FOR PREPARING LIPID NANOPARTICLES ENCAPSULATING AN AGENT, NANOPARTICLE COMPOSITION COMPRISING SAID COMPOUND AND RELATED METHODS THEREOF | Agency for Science, Technology and Research (SG) | 2026-03-18 | — | — | EP | disclosed |
| US-12486359-B2 | Method for preparing controlled peptide-based polymers and copolymers in an aqueous solution | UNIVERSITÉ DE BORDEAUX (FR) | 2025-12-02 | — | — | US | disclosed |
| WO-2024232832-A1 | A COMPOUND FOR PREPARING LIPID NANOPARTICLES ENCAPSULATING AN AGENT, NANOPARTICLE COMPOSITION COMPRISING SAID COMPOUND AND RELATED METHODS THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2024-11-14 | — | — | WO | disclosed |
| CN-117860908-A | Double-drug nano-drug delivery system with cisplatin drug and proteinase K coupled and preparation method thereof | 浙江大学长三角智慧绿洲创新中心 | 2024-04-12 | — | — | CN | disclosed |
| US-20240109875-A1 | NOVEL METHOD FOR SYNTHESIZING NCA COMPOUNDS | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE MONTPELLIER (ENSCM) (FR) | 2024-04-04 | — | — | US | disclosed |
| WO-2024028255-A1 | POLY(AMINO ACID) BASED CAPSULES | AGFA-GEVAERT NV (BE) | 2024-02-08 | — | — | WO | disclosed |
| US-20230277677-A1 | POLYMERIC CONJUGATES AND USES THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2023-09-07 | — | — | US | disclosed |
| EP-4072530-B1 | STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY | CENTRE NAT RECH SCIENT (FR) | 2023-08-30 | — | — | EP | disclosed |
| US-20100145018-A1 | Lipid-Polymer-Conjugates | ASTELLAS PHARMA EUROPE BV (NL) | 2010-06-10 | — | — | US | disclosed |
| US-20100145018-A1 | Lipid-Polymer-Conjugates | ASTELLAS PHARMA EUROPE BV (NL) | 2010-06-10 | — | — | US | disclosed |
| US-20090131589-A1 | CONTROLLED MOLECULAR WEIGHT AMINO ACID POLYMERS HAVING FUNCTIONALIZABLE BACKBONES AND END GROUPS AND PROCESSES FOR PREPARING THE SAME | UNIVERSITY OF ALABAMA IN HUNTSVILLE | 2009-05-21 | — | — | US | disclosed |
| WO-2009058291-A2 | CONTROLLED MOLECULAR WEIGHT AMINO ACID POLYMERS HAVING FUNCTIONALIZABLE BACKBONES AND END GROUPS AND PROCESSES FOR PREPARING THE SAME | UNIVERSITY OF ALABAMA IN HUNTSVILLE (US) | 2009-05-07 | — | — | WO | disclosed |
| US-20080069902-A1 | Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2008-03-20 | — | — | US | disclosed |
| US-20080069902-A1 | Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2008-03-20 | — | — | US | disclosed |
| US-7316811-B2 | Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2008-01-08 | — | — | US | disclosed |
| US-7316811-B2 | Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2008-01-08 | — | — | US | disclosed |
| US-7202954-B2 | Target detecting apparatus, target detection method and target detection substrate | FUJI PHOTO FILM CO., LTD. (JP) | 2007-04-10 | — | — | US | disclosed |
| US-7202954-B2 | Target detecting apparatus, target detection method and target detection substrate | FUJI PHOTO FILM CO., LTD. (JP) | 2007-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100145018-A1 | Lipid-Polymer-Conjugates | PARG, GLUL, PHOSPHO1 | ALDH1A1 4637/4885MAPK1 4631/4885L3MBTL1 881/4885 |
| US-20230277677-A1 | POLYMERIC CONJUGATES AND USES THEREOF | CD44, DCLRE1A, CD74 | ALDH1A1 2653/4885MAPK1 3732/4885L3MBTL1 528/4885 |
| US-20240109875-A1 | NOVEL METHOD FOR SYNTHESIZING NCA COMPOUNDS | NPPA, NGLY1, NAAA | ALDH1A1 4529/4885MAPK1 2175/4885L3MBTL1 3696/4885 |
| US-20080069902-A1 | Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles | INCENP, IAPP, PGF | ALDH1A1 3526/4885MAPK1 3881/4885L3MBTL1 3047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.